Video

Ishwaria Mohan Subbiah on Older Patients Enrolled in Clinical Trials

Ishwaria Mohan Subbiah, a physician at the MD Anderson Cancer Center, discusses elderly people on clinical trials.

Ishwaria Mohan Subbiah, a physician at the MD Anderson Cancer Center, discusses elderly people on clinical trials.

After observing 1,400 patients on phase 1 clinical trials at MD Anderson Cancer, Subbiah realized that patients over the age of 65 had similarly positive clinical outcomes as younger cohorts. However, she also found that while these older patients make up about half of the new cancer cases each year in the United States, they make up a much smaller proportion of patients enrolled in clinical trials.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
Image of doctor.
Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Image of woman.
Image of woman.
Image of woman.